NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

AI-Based Symptom Management for Post-Treatment Breast Cancer Survivors

Not Yet RecruitingNA

Sponsor: Hong Kong Metropolitan University

Conditions: Breast Cancer, Cancer Survivorship

Interventions: AIMS platform

This pilot randomized controlled trial will test the feasibility and acceptability of an Artificial Intelligence-based Multidimensional Symptom Management (AIMS) intervention for post-treatment breast cancer survivors. Thirty-six participants will be randomly assigned (1:1) to receive either the AIMS intervention or usual care. Outcomes include feasibility (recruitment and retention), adherence, acceptability, symptom burden, psychological distress, quality of life, and safety of the AIMS intervention.

Eligibility overview

Sex: FEMALE

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Female breast cancer survivors aged 18 years or older
* Experiencing at least one symptom in the past month (e.g., fatigue, pain and insomnia, a score of ≥2 on the 0-10 Numeric Rating Scale (0 = "no fatigue", 10 = "worst fatigue")
* Completed primary treatment (surgery, chemotherapy, or radiotherapy) within the last 24 months
* Able to read Chinese and use a smartphone or tablet

Exclusion Criteria:

* Unstable medical condition
* Severe psychiatric disorders or cognitive impairment
* Participation in another interventional study